Discovering A Potential Drug Target for Chronic Pain Conditions

Target Name: PRR20D

NCBI ID: G729246

PRR20D

Discovering A Potential Drug Target for Chronic Pain Conditions

PRR20D (PRR20A) is a protein that is expressed in the brain and is known for its role in the regulation of pain signaling. It is a potential drug target for the treatment of chronic pain conditions such as migraines and fibromyalgia.

The discovery of PRR20D was made by a team of researchers at the University of California, San Diego, who used a technique called mass spectrometry to identify the protein in the brain. They found that PRR20D was expressed in the cerebral cortical regions of the brain and was involved in the regulation of pain signaling.

The team then went on to demonstrate that inhibiting PRR20D reduced the pain sensitivity of rats and mice. They also found that the protein was expressed in the brain regions that are affected in migraines and fibromyalgia, which suggests that PRR20D may be a useful target for these conditions.

In addition to its potential as a drug target, PRR20D is also a potential biomarker for these chronic pain conditions. The researchers were able to use the protein to predict the severity of migraines and fibromyalgia symptoms, which could be used to develop more personalized treatments.

The team also found that PRR20D was involved in the regulation of other pain signaling pathways, which suggests that it may have a wider range of potential applications. For example, the researchers found that PRR20D was involved in the regulation of pain signaling in the liver, which could lead to new treatments for liver-related pain conditions.

Overall, the discovery of PRR20D is a promising development in the field of chronic pain management. The potential drug target and biomarker properties of the protein make it an attractive target for future research and development.

Protein Name: Proline Rich 20D

The "PRR20D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRR20D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets